Downloads: 120
China | Economics Management | Volume 8 Issue 9, September 2019 | Pages: 1170 - 1174
The Influence of Executive Shareholding in Pharmaceutical Industry on Corporate Performance from the Perspective of R&D
Abstract: This paper takes 138 pharmaceutical manufacturing listed companies in 2008-2018 as researchsamples, proposes hypotheses and establishes multiple regression models for empirical research, and explores the impact of executive shareholding ratio on firm performance, and between executives' holdings and R & D investment. The relationship between R & D expenditure as an intermediary variable between equity incentives and firm performance, explores the impact of executive shareholdings on firm performance through R & D investment, and provides a reference for pharmaceutical manufacturing listed companies to improve performance and maximize value.
Keywords: Executive shareholding, R&D investment, company performance
How to Cite?: Zhao Fei, "The Influence of Executive Shareholding in Pharmaceutical Industry on Corporate Performance from the Perspective of R&D", Volume 8 Issue 9, September 2019, International Journal of Science and Research (IJSR), Pages: 1170-1174, https://www.ijsr.net/getabstract.php?paperid=16091904, DOI: https://dx.doi.org/10.21275/16091904